These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1149 related items for PubMed ID: 18852348
1. Sodium oxybate for excessive daytime sleepiness in Parkinson disease: an open-label polysomnographic study. Ondo WG, Perkins T, Swick T, Hull KL, Jimenez JE, Garris TS, Pardi D. Arch Neurol; 2008 Oct; 65(10):1337-40. PubMed ID: 18852348 [Abstract] [Full Text] [Related]
2. The nightly administration of sodium oxybate results in significant reduction in the nocturnal sleep disruption of patients with narcolepsy. Black J, Pardi D, Hornfeldt CS, Inhaber N. Sleep Med; 2009 Sep; 10(8):829-35. PubMed ID: 19616998 [Abstract] [Full Text] [Related]
3. Sodium Oxybate for Excessive Daytime Sleepiness and Sleep Disturbance in Parkinson Disease: A Randomized Clinical Trial. Büchele F, Hackius M, Schreglmann SR, Omlor W, Werth E, Maric A, Imbach LL, Hägele-Link S, Waldvogel D, Baumann CR. JAMA Neurol; 2018 Jan 01; 75(1):114-118. PubMed ID: 29114733 [Abstract] [Full Text] [Related]
4. Effects of ropinirole prolonged-release on sleep disturbances and daytime sleepiness in Parkinson disease. Dusek P, Busková J, Růzicka E, Majerová V, Srp A, Jech R, Roth J, Sonka K. Clin Neuropharmacol; 2010 Jul 01; 33(4):186-90. PubMed ID: 20661025 [Abstract] [Full Text] [Related]
5. A randomized, double blind, placebo-controlled multicenter trial comparing the effects of three doses of orally administered sodium oxybate with placebo for the treatment of narcolepsy. Sleep; 2002 Feb 01; 25(1):42-9. PubMed ID: 11833860 [Abstract] [Full Text] [Related]
6. Sodium oxybate relieves pain and improves function in fibromyalgia syndrome: a randomized, double-blind, placebo-controlled, multicenter clinical trial. Russell IJ, Perkins AT, Michalek JE, Oxybate SXB-26 Fibromyalgia Syndrome Study Group. Arthritis Rheum; 2009 Jan 01; 60(1):299-309. PubMed ID: 19116896 [Abstract] [Full Text] [Related]
7. The effects of sodium oxybate on clinical symptoms and sleep patterns in patients with fibromyalgia. Scharf MB, Baumann M, Berkowitz DV. J Rheumatol; 2003 May 01; 30(5):1070-4. PubMed ID: 12734908 [Abstract] [Full Text] [Related]
8. A double-blind, placebo-controlled study demonstrates sodium oxybate is effective for the treatment of excessive daytime sleepiness in narcolepsy. Xyrem International Study Group. J Clin Sleep Med; 2005 Oct 15; 1(4):391-7. PubMed ID: 17564408 [Abstract] [Full Text] [Related]
9. Long-term effect of initiating pramipexole vs levodopa in early Parkinson disease. Parkinson Study Group CALM Cohort InvestigatorsDepartment of Neurology, University of Rochester, 1351 Mt Hope Ave, Ste 220, Rochester, NY 14620, USA. kevin.biglan@ctcc.rochester.edu. Arch Neurol; 2009 May 15; 66(5):563-70. PubMed ID: 19433655 [Abstract] [Full Text] [Related]
10. Sodium oxybate in the treatment of childhood narcolepsy-cataplexy: a retrospective study. Mansukhani MP, Kotagal S. Sleep Med; 2012 Jun 15; 13(6):606-10. PubMed ID: 22445591 [Abstract] [Full Text] [Related]
11. Sleepiness in Parkinson's disease: a controlled study. Brodsky MA, Godbold J, Roth T, Olanow CW. Mov Disord; 2003 Jun 15; 18(6):668-72. PubMed ID: 12784270 [Abstract] [Full Text] [Related]
12. Predictors of impaired daytime sleep and wakefulness in patients with Parkinson disease treated with older (ergot) vs newer (nonergot) dopamine agonists. Razmy A, Lang AE, Shapiro CM. Arch Neurol; 2004 Jan 15; 61(1):97-102. PubMed ID: 14732626 [Abstract] [Full Text] [Related]
13. The range and nature of sleep dysfunction in untreated Parkinson's disease (PD). A comparative controlled clinical study using the Parkinson's disease sleep scale and selective polysomnography. Dhawan V, Dhoat S, Williams AJ, Dimarco A, Pal S, Forbes A, Tobías A, Martinez-Martin P, Chaudhuri KR. J Neurol Sci; 2006 Oct 25; 248(1-2):158-62. PubMed ID: 16780888 [Abstract] [Full Text] [Related]
14. Sleep and sleepiness in patients with Parkinson's disease before and after dopaminergic treatment. Kaynak D, Kiziltan G, Kaynak H, Benbir G, Uysal O. Eur J Neurol; 2005 Mar 25; 12(3):199-207. PubMed ID: 15693809 [Abstract] [Full Text] [Related]
15. A multicenter, open-label, sequential study comparing preferences for carbidopa-levodopa orally disintegrating tablets and conventional tablets in subjects with Parkinson's disease. Nausieda PA, Pfeiffer RF, Tagliati M, Kastenholz KV, DeRoche C, Slevin JT. Clin Ther; 2005 Jan 25; 27(1):58-63. PubMed ID: 15763606 [Abstract] [Full Text] [Related]
16. [The relationship between subjective sleepiness and polysomnographic findings in sleep apnea syndrome]. Yagi T, Noda A, Itoh R, Yamada H, Nakashima N, Yokota M, Koike Y. Rinsho Byori; 1998 Nov 25; 46(11):1168-72. PubMed ID: 9868304 [Abstract] [Full Text] [Related]
17. Fatigue in systemic lupus erythematosus: contributions of disordered sleep, sleepiness, and depression. Iaboni A, Ibanez D, Gladman DD, Urowitz MB, Moldofsky H. J Rheumatol; 2006 Dec 25; 33(12):2453-7. PubMed ID: 17143980 [Abstract] [Full Text] [Related]
18. Clinical usefulness of the Parkinson's disease sleep scale. Tse W, Liu Y, Barthlen GM, Hälbig TD, Tolgyesi SV, Gracies JM, Olanow CW, Koller WC. Parkinsonism Relat Disord; 2005 Aug 25; 11(5):317-21. PubMed ID: 15882956 [Abstract] [Full Text] [Related]
19. Modafinil for the treatment of daytime sleepiness in Parkinson's disease: a double-blind, randomized, crossover, placebo-controlled polygraphic trial. Högl B, Saletu M, Brandauer E, Glatzl S, Frauscher B, Seppi K, Ulmer H, Wenning G, Poewe W. Sleep; 2002 Dec 25; 25(8):905-9. PubMed ID: 12489899 [Abstract] [Full Text] [Related]
20. The impact of obstructive sleep apnea and daytime sleepiness on work limitation. Mulgrew AT, Ryan CF, Fleetham JA, Cheema R, Fox N, Koehoorn M, Fitzgerald JM, Marra C, Ayas NT. Sleep Med; 2007 Dec 25; 9(1):42-53. PubMed ID: 17825611 [Abstract] [Full Text] [Related] Page: [Next] [New Search]